Targeting EGFR in HPV-associated cancer

Joseph A. Sparano; Missak Haigentz; Mark H. Einstein

doi:10.1007/978-1-4419-1513-9_13

Targeting EGFR in HPV-associated cancer

Joseph A. Sparano, Missak Haigentz, Mark H. Einstein

Medicine

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

Squamous cell carcinoma of the cervix, anal canal, and hypopharynx is known to be associated with human papilloma virus (HPV) infection. HPV is a double-stranded DNA virus that encodes oncogenic proteins, including E5, E6, and E7. E5 activates epidermal growth factor receptor (EGFR) by binding to its 16 kDa subunit of protein pump ATPase, thereby promoting proto-oncogene expression, inhibits the expression of the tumor suppressor gene p21, and amplifies mitogenic EGFR signals. In addition, E6 and E6 proteins bind to p53 and pRb, respectively, resulting in reduced levels and function of p53 and pRb within the cell, thereby inhibiting apoptosis and promoting genomic instability. EGFR-directed therapies are effective treatments for squamous cell carcinoma of the head and neck and are also being evaluated in other HPV-associated tumors.

Original language	English (US)
Title of host publication	Molecular Basis for Therapy of AIDS-Defining Cancers
Publisher	Springer New York
Pages	211-234
Number of pages	24
ISBN (Print)	9781441915122
DOIs	https://doi.org/10.1007/978-1-4419-1513-9_13
State	Published - 2010

ASJC Scopus subject areas

General Biochemistry, Genetics and Molecular Biology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/978-1-4419-1513-9_13

Cite this

@inbook{68778f488c2d459299a7a06d7db39990,

title = "Targeting EGFR in HPV-associated cancer",

abstract = "Squamous cell carcinoma of the cervix, anal canal, and hypopharynx is known to be associated with human papilloma virus (HPV) infection. HPV is a double-stranded DNA virus that encodes oncogenic proteins, including E5, E6, and E7. E5 activates epidermal growth factor receptor (EGFR) by binding to its 16 kDa subunit of protein pump ATPase, thereby promoting proto-oncogene expression, inhibits the expression of the tumor suppressor gene p21, and amplifies mitogenic EGFR signals. In addition, E6 and E6 proteins bind to p53 and pRb, respectively, resulting in reduced levels and function of p53 and pRb within the cell, thereby inhibiting apoptosis and promoting genomic instability. EGFR-directed therapies are effective treatments for squamous cell carcinoma of the head and neck and are also being evaluated in other HPV-associated tumors.",

author = "Sparano, {Joseph A.} and Missak Haigentz and Einstein, {Mark H.}",

year = "2010",

doi = "10.1007/978-1-4419-1513-9_13",

language = "English (US)",

isbn = "9781441915122",

pages = "211--234",

booktitle = "Molecular Basis for Therapy of AIDS-Defining Cancers",

publisher = "Springer New York",

}

TY - CHAP

T1 - Targeting EGFR in HPV-associated cancer

AU - Sparano, Joseph A.

AU - Haigentz, Missak

AU - Einstein, Mark H.

PY - 2010

Y1 - 2010

N2 - Squamous cell carcinoma of the cervix, anal canal, and hypopharynx is known to be associated with human papilloma virus (HPV) infection. HPV is a double-stranded DNA virus that encodes oncogenic proteins, including E5, E6, and E7. E5 activates epidermal growth factor receptor (EGFR) by binding to its 16 kDa subunit of protein pump ATPase, thereby promoting proto-oncogene expression, inhibits the expression of the tumor suppressor gene p21, and amplifies mitogenic EGFR signals. In addition, E6 and E6 proteins bind to p53 and pRb, respectively, resulting in reduced levels and function of p53 and pRb within the cell, thereby inhibiting apoptosis and promoting genomic instability. EGFR-directed therapies are effective treatments for squamous cell carcinoma of the head and neck and are also being evaluated in other HPV-associated tumors.

AB - Squamous cell carcinoma of the cervix, anal canal, and hypopharynx is known to be associated with human papilloma virus (HPV) infection. HPV is a double-stranded DNA virus that encodes oncogenic proteins, including E5, E6, and E7. E5 activates epidermal growth factor receptor (EGFR) by binding to its 16 kDa subunit of protein pump ATPase, thereby promoting proto-oncogene expression, inhibits the expression of the tumor suppressor gene p21, and amplifies mitogenic EGFR signals. In addition, E6 and E6 proteins bind to p53 and pRb, respectively, resulting in reduced levels and function of p53 and pRb within the cell, thereby inhibiting apoptosis and promoting genomic instability. EGFR-directed therapies are effective treatments for squamous cell carcinoma of the head and neck and are also being evaluated in other HPV-associated tumors.

UR - http://www.scopus.com/inward/record.url?scp=84900239716&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84900239716&partnerID=8YFLogxK

U2 - 10.1007/978-1-4419-1513-9_13

DO - 10.1007/978-1-4419-1513-9_13

M3 - Chapter

AN - SCOPUS:84900239716

SN - 9781441915122

SP - 211

EP - 234

BT - Molecular Basis for Therapy of AIDS-Defining Cancers

PB - Springer New York

ER -

Targeting EGFR in HPV-associated cancer

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this